Aegerion Pharmaceuticals, Inc.Enters Oversold Territory - Tale of the Tape


Aegerion Pharmaceuticals, Inc. 's ( AEGR ) share price has entered into oversold territory with a stochastic value of 7.5739. The Zacks Consensus Estimate on the company's loss for December 2012 decreased by 21 cents over the past two months to $2.29 per share. Aegerion Pharmaceuticals, Inc. is a Zacks #2 Rank (" Buy") company.


AEGERION PHARMA (AEGR): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: AEGR

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by